Recombinant Enterococcus faecalis MutS2 protein (mutS2), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder

Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this in your order notes; we will fulfill your request to the best of our ability.

Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.

Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.

Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on various factors: storage conditions, buffer composition, temperature, and the protein's inherent stability.

Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C. Lyophilized formulations have a 12-month shelf life at -20°C/-80°C.

Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process.

Tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its incorporation.

Synonyms
mutS2; EF_1404; Endonuclease MutS2; EC 3.1.-.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Enterococcus faecalis (strain ATCC 700802 / V583)
Target Names
mutS2
Uniprot No.

Target Background

Function
Endonuclease involved in suppressing homologous recombination; it likely plays a crucial role in regulating bacterial genetic diversity.
Database Links

KEGG: efa:EF1404

STRING: 226185.EF1404

Protein Families
DNA mismatch repair MutS family, MutS2 subfamily

Q&A

What is the functional role of MutS2 in Enterococcus faecalis?

MutS2 in E. faecalis, like its homologs in other bacterial species, plays crucial roles in DNA recombination and repair processes . While traditional MutS1-family proteins primarily function in DNA mismatch repair (MMR), MutS2 proteins have evolved distinct functions . Based on comparative studies with other bacterial MutS2 proteins, E. faecalis MutS2 likely contributes to:

  • Regulation of homologous recombination events

  • Protection against foreign DNA through nuclease activity

  • Maintenance of genomic integrity during stress conditions

Recent findings in Bacillus subtilis suggest MutS2 may also function in ribosome quality control by resolving stalled translation complexes, splitting them into subunits . This indicates MutS2 may have broader roles in cellular stress responses beyond DNA metabolism.

Methodologically, researchers investigating MutS2 function should consider both genetic approaches (targeted gene disruption) and biochemical characterization of the purified protein to fully elucidate its roles in E. faecalis.

How does E. faecalis MutS2 differ structurally from other bacterial MutS proteins?

E. faecalis MutS2 differs from MutS1-family proteins and shows specific structural characteristics:

DomainFunction in MutS2Comparison to MutS1
N-terminalATPase activity (Walker motifs)Present in both families but with sequence variations
Middle regionDNA bindingLacks mismatch recognition domain found in MutS1
C-terminalSMR (Small MutS-Related) domain with nuclease activityAbsent in MutS1; distinctive to MutS2 family
KOW domainPotential ribosome interactionNot present in MutS1 proteins

The most distinctive structural feature of MutS2 is the presence of the SMR domain, which confers nuclease activity absent in MutS1 proteins . Based on structural studies of B. subtilis MutS2, the SMR domain appears to be crucial for recognizing and resolving stalled ribosomes, suggesting a potential similar role in E. faecalis .

Researchers should note that while E. faecalis MutS2 shares domain architecture with other bacterial MutS2 proteins, species-specific variations may exist that influence substrate specificity and regulation.

What expression systems are most effective for producing recombinant E. faecalis MutS2?

Based on successful approaches with other bacterial MutS2 proteins, the following expression systems can be considered:

  • E. coli-based expression systems:

    • BL21(DE3) strain with pET-based vectors offers high-yield expression

    • Arctic Express strains may improve folding at lower temperatures

    • Codon optimization is recommended as E. faecalis uses a different codon bias than E. coli

  • Protein solubility considerations:

    • Expression as fusion proteins with solubility tags (MBP, SUMO, GST) often improves yield

    • Inclusion of the Walker B mutation (E416A) can prevent ATP hydrolysis and improve stability

  • Purification strategy:

    • Sequential chromatography combining affinity (His-tag), ion exchange, and size exclusion

    • Typical yield: 2-5 mg of purified protein per liter of culture

When validating expression, researchers should confirm proper folding using circular dichroism and functional assays for ATPase and nuclease activities. For structural studies requiring native protein, consider FLAG-tagged constructs expressed in B. subtilis as an alternative model, as demonstrated in previous studies .

How can researchers investigate the role of MutS2 in E. faecalis pathogenicity?

E. faecalis is both a commensal and an opportunistic pathogen responsible for various infections, including surgical site infections and diabetic ulcers . To investigate MutS2's potential role in pathogenicity:

  • Construction of mutS2 knockout strains:

    • Use allelic exchange methodology similar to that employed for H. pylori ΔmutS2 strains

    • Insert a chloramphenicol acetyl transferase (CAT) cassette within the mutS2 sequence

    • Introduce the disrupted mutS2 gene into E. faecalis via natural transformation

    • Confirm disruption by PCR and direct sequencing

  • Comparative virulence studies:

    • Infection models (C. elegans, G. mellonella, murine models)

    • Biofilm formation assays (crystal violet staining, confocal microscopy)

    • Immune evasion assessments (macrophage and neutrophil interaction studies)

  • Transcriptomic analysis:

    • Compare wild-type and ΔmutS2 strains during infection using RNA-seq

    • Focus on genes involved in virulence factor expression, stress responses, and antibiotic resistance

E. faecalis has mechanisms to evade and suppress immune clearance, including suppression of pro-inflammatory responses and prevention of neutrophil extracellular trap formation . Researchers should examine whether MutS2 influences these immune evasion processes, particularly given the potential role of MutS2 in stress responses.

What methodologies are optimal for studying MutS2-ribosome interactions in E. faecalis?

Based on recent findings in B. subtilis MutS2, which revealed a novel role in ribosome rescue , researchers investigating similar functions in E. faecalis MutS2 should consider:

  • Structural approaches:

    • Cryo-electron microscopy (cryo-EM) of MutS2-ribosome complexes

    • Focus on capturing collision states using translation inhibitors like chloramphenicol (CAM)

    • Both in vitro reconstituted and natively purified complexes should be examined

  • Biochemical validation:

    • Ribosome binding assays using gradient sedimentation

    • Site-directed mutagenesis of key domains:

      • KOW domain (Q668A, I671A, L672A, K673A equivalent residues)

      • SMR domain (conserved residues near H743 and the GxG motif)

  • In vivo functional studies:

    • Reporter constructs to monitor translation of problematic mRNAs

    • Construct design should include:

      • Translational fusions (e.g., NanoLuc to BleR)

      • Stalling motifs (e.g., ApdA equivalent in E. faecalis)

  • Data analysis approach:

    • Quantify truncated protein products by western blotting

    • Compare wild-type and mutant MutS2 effects on ribosome collision resolution

    • Assess polysome profiles with and without collision-inducing treatments

Domain MutationExpected Effect on Ribosome BindingValidation Method
KOW domain mutationsReduced binding to monosomesGradient sedimentation
SMR domain deletionDramatic reduction in collision sensingGradient sedimentation
Walker B (E416A)Little effect on bindingGradient sedimentation
H743A equivalentReduced ribosome splitting activityIn vivo reporter assay

These methodologies draw from successful approaches with B. subtilis MutS2 and should be adapted for E. faecalis-specific characteristics.

How do mutations in MutS2 affect genetic stability and antibiotic resistance in E. faecalis?

Mutations in DNA repair proteins like MutS and MutL have been associated with hypermutator phenotypes in various bacterial species . For E. faecalis MutS2:

  • Mutation rate assessment:

    • Fluctuation analysis to determine spontaneous mutation frequencies

    • Rifampicin resistance emergence assay as a marker for mutation rate

    • Comparative analysis between wild-type and mutS2 variant strains

  • Antibiotic resistance development:

    • Serial passage experiments in sub-inhibitory antibiotic concentrations

    • Focus on antibiotics requiring specific mutations for resistance (e.g., linezolid)

    • Sequence analysis of target genes before and after selection

  • Genetic analysis of clinical isolates:

    • Screen for natural MutS2 variants in clinical E. faecalis isolates

    • Correlate sequence variations with antibiotic resistance profiles

    • Consider strain lineage effects (e.g., specific clonal complexes may have characteristic mutations)

Previous research with E. faecium found specific amino acid substitutions in MutS proteins from certain lineages (e.g., CC17) . While not proven to cause hypermutator phenotypes, these variations might influence genetic stability. A similar analysis of E. faecalis MutS2 variants could reveal lineage-specific patterns relevant to antibiotic resistance development.

What techniques are recommended for characterizing the nuclease activity of recombinant E. faecalis MutS2?

The SMR domain of MutS2 proteins possesses nuclease activity crucial for their function . To characterize this activity:

  • Substrate preparation:

    • Linear DNA (PCR products, restriction fragments)

    • Circular DNA (plasmids in supercoiled and nicked forms)

    • RNA substrates (in vitro transcribed, with and without secondary structures)

    • DNA:RNA hybrids to test substrate specificity

  • Nuclease assay conditions:

    • Buffer composition: Typically Tris-HCl (pH 7.5-8.0), MgCl₂ (5-10 mM), NaCl (50-100 mM)

    • Temperature range: 25-37°C

    • Time course: 0-60 minutes with sampling at regular intervals

    • Controls: Heat-inactivated enzyme, EDTA inhibition

  • Activity detection methods:

    • Gel electrophoresis (agarose for DNA, PAGE for RNA)

    • Fluorescence-based assays using labeled substrates

    • Real-time monitoring using PicoGreen or equivalent dyes

  • Kinetic analysis:

    • Determination of Km and Vmax using varied substrate concentrations

    • Assessment of metal ion dependence (Mg²⁺, Mn²⁺, Ca²⁺)

    • pH profile to determine optimum conditions

  • Mutational analysis:

    • Site-directed mutagenesis of conserved residues in the SMR domain

    • Focus on residues equivalent to those critical in B. subtilis MutS2 (e.g., H743)

    • Quantitative comparison of wild-type and mutant activities

Substrate TypeExpected ActivityDetection MethodControl
Linear dsDNAModerateAgarose gelDNase I
Supercoiled plasmidVariable (nicking)Agarose gelNicking enzyme
RNAPotentially highUrea-PAGERNase A
DNA:RNA hybridStructure-dependentBoth gel typesRNase H

How can researchers effectively design and construct E. faecalis mutS2 knockout strains?

Based on successful approaches with related organisms :

  • Target gene identification and analysis:

    • Obtain the complete sequence of E. faecalis mutS2 from reference genomes

    • Analyze flanking regions for designing homologous recombination

    • Identify unique restriction sites within the gene for insertion of selection markers

  • Knockout strategy:

    • Amplify a fragment containing the mutS2 gene (~2.5 kb) using PCR

    • Clone into a suitable vector (e.g., pGEM-T)

    • Insert an antibiotic resistance cassette (e.g., chloramphenicol acetyltransferase) at an appropriate restriction site

    • Transform the construct into E. faecalis via natural transformation or electroporation

    • Select transformants using the appropriate antibiotic

  • Verification methods:

    • PCR confirmation showing increased fragment size due to cassette insertion

    • Direct sequencing of the PCR fragment to confirm cassette orientation

    • RT-PCR to confirm absence of functional mutS2 transcript

    • Western blot to verify absence of MutS2 protein

  • Complementation:

    • Reintroduce wild-type mutS2 at an ectopic location to confirm phenotype specificity

    • Use inducible promoters for controlled expression studies

    • Include epitope tags for monitoring expression levels

This methodology has been successfully applied to create ΔmutS2 strains in related organisms like H. pylori and can be adapted for E. faecalis with appropriate modifications for transformation efficiency and selection markers suitable for enterococci.

How should researchers analyze contradictory findings about MutS2 function across different studies?

Researchers may encounter conflicting data regarding MutS2 function, as illustrated by discrepancies in structural studies of B. subtilis MutS2 . A systematic approach to reconciling contradictions includes:

  • Methodological comparison:

    • Examine differences in experimental conditions (in vitro vs. in vivo)

    • Compare protein constructs (full-length vs. truncated, tag position)

    • Evaluate expression systems and purification protocols

  • Structural heterogeneity analysis:

    • Consider conformational diversity in cryo-EM datasets

    • Analyze different functional states (e.g., ATP-bound vs. nucleotide-free)

    • Assess interactions with binding partners (e.g., ribosome conformational states)

  • Strain background effects:

    • Compare results across different isolates and reference strains

    • Consider genomic context and potential compensatory mechanisms

    • Evaluate growth conditions that might influence protein function

  • Reconciliation strategies:

    • Direct comparative experiments under identical conditions

    • Collaboration between laboratories reporting discrepancies

    • Meta-analysis of published data with statistical assessment

When confronted with contradictory findings about E. faecalis MutS2, researchers should consider that both sets of data may reflect different aspects of a complex, multifunctional protein. The apparently contradictory results regarding B. subtilis MutS2-ribosome interactions ultimately revealed insights about dynamic conformational states relevant to function.

What statistical approaches are recommended for analyzing MutS2 sequence conservation across E. faecalis strains?

To analyze MutS2 sequence variations across E. faecalis strains:

  • Sequence acquisition and alignment:

    • Collect MutS2 sequences from diverse E. faecalis isolates

    • Include clinical, commensal, and environmental strains

    • Use MUSCLE or MAFFT for multiple sequence alignment

  • Conservation analysis:

    • Calculate per-residue conservation scores

    • Generate sequence logos for highly variable regions

    • Map conservation onto structural models

  • Statistical tests for selection:

    • dN/dS ratio calculation to identify selection pressures

    • McDonald-Kreitman test to compare within-species polymorphism

    • Tajima's D to detect departures from neutral evolution

  • Correlation with phenotypic data:

    • Associate sequence clusters with antibiotic resistance profiles

    • Correlate specific mutations with hypermutator phenotypes

    • Analyze strain epidemiology in relation to MutS2 variants

Analysis TypePurposeSoftware/ToolOutput Format
Sequence conservationIdentify constrained regionsConSurf, JalviewHeat maps, conservation scores
Selection analysisDetect evolutionary pressurePAML, HyPhydN/dS values, p-values
Polymorphism assessmentIdentify significant variantsDnaSP, MEGANucleotide diversity, haplotype analysis
Structure mappingVisualize functional impactPyMOL, UCSF Chimera3D models with conservation coloring

This approach has revealed important MutS variants in E. faecium lineages (e.g., CC17) and could similarly identify functionally significant MutS2 variants in E. faecalis.

What emerging roles of MutS2 in stress response should researchers investigate in E. faecalis?

Recent findings suggest broader functions for MutS2 beyond traditional DNA metabolism . Priority areas for future investigation include:

  • Ribosome quality control mechanisms:

    • Determine if E. faecalis MutS2 recognizes and resolves stalled ribosomes

    • Investigate potential collaboration with other ribosome rescue factors

    • Assess impact on translation fidelity during stress conditions

  • Oxidative stress response:

    • Examine MutS2 regulation under oxidative conditions relevant to host-pathogen interactions

    • Investigate protection against oxidative DNA damage

    • Assess potential sensing of oxidized nucleotides

  • Biofilm formation and persistence:

    • Analyze MutS2 expression in biofilm vs. planktonic states

    • Compare wild-type and ΔmutS2 strains for biofilm architecture

    • Investigate connections to persister cell formation

  • Interaction with host immunity:

    • Study MutS2 regulation during macrophage or neutrophil encounters

    • Investigate potential role in the anti-inflammatory signatures observed during E. faecalis infection

    • Assess contribution to intracellular persistence within host cells

E. faecalis can evade immune clearance through multiple mechanisms, including suppression of pro-inflammatory responses and prevention of neutrophil extracellular trap formation . The potential contribution of MutS2 to these processes, particularly through stress response modulation, represents an important avenue for future research.

How might novel antimicrobial strategies target E. faecalis MutS2 function?

Given the emerging roles of MutS2 in stress response and potential contributions to pathogenicity, targeting this protein could offer novel antimicrobial approaches:

  • Inhibitor development strategies:

    • Structure-based design targeting the SMR nuclease domain

    • Allosteric inhibitors disrupting MutS2-ribosome interactions

    • ATPase inhibitors affecting nucleotide-dependent conformational changes

  • Combination therapy approaches:

    • MutS2 inhibitors with conventional antibiotics

    • Targeting MutS2 to prevent development of resistance to other drugs

    • Potentiation of host immune clearance mechanisms

  • Anti-virulence applications:

    • Modulation of MutS2 to reduce biofilm formation capacity

    • Interference with MutS2-mediated stress responses during infection

    • Attenuation of E. faecalis persistence within host cells

  • Genetic stability disruption:

    • Synthetic lethality approaches targeting pathways dependent on MutS2

    • Induction of toxic recombination intermediates in MutS2-inhibited cells

    • Combination with DNA-damaging agents to overwhelm repair capacity

These approaches would require detailed structural and functional characterization of E. faecalis MutS2, but could potentially address the significant clinical challenge posed by E. faecalis infections, particularly those involving biofilm formation and immune evasion .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.